Complications After Dual Placement of a Baclofen Pump and Ventricular Shunt in Individuals With Severe Brain Injury.
Elke Pucks-Faes, Judith Dobesberger, Lucas-Michael Halbmayer and 3 others
PMID 33543105WHAT IT FOUND
In 9 patients with severe brain injury who received both a baclofen pump and a ventricular shunt, 8 experienced complications.
Most issues occurred within 4 days of the second implant. The authors recommend testing the first system, starting baclofen slowly, and monitoring closely.
Key findings
01Complications occurred in 8 out of 9 patients who had both an intrathecal baclofen (ITB) device and a ventricular shunt (VPS) system implanted.
02More than 80% of these complications were encountered within the first 4 days after the implantation of the second system.
03Drug-related complications, specifically signs of baclofen overdose or intoxication, were among the most common problems detected.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study included only 9 patients, which is a very small sample size for drawing general conclusions. The design was retrospective, relying on existing medical records rather than prospective data collection. The patient population was heterogeneous in terms of pathology (traumatic brain injury, hemorrhage) and the order of device implantation. The study did not include a control group of patients with only one device, so it cannot definitively prove that the combination caused higher complication rates compared to separate implants, although the authors suggest this based on literature.
Declared interests
The paper does not explicitly state funding sources or conflicts of interest in the provided text, but it is a retrospective analysis from a single department. Suppliers of the devices (Codman, Smiths Medical, Canè S.p.A.) are listed, but no direct industry involvement in the study design or analysis is reported.
The easy way to misread this
Do not assume this high complication rate applies to all patients with both devices. The sample was very small (9 patients) and retrospective. While the authors recommend caution, these findings are preliminary and do not prove that the combination is inherently unsafe for everyone, only that it requires careful monitoring in this specific case series.